Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/27/2025

Sickle Cell Disease Pathophysiology and Management

Introduction to Sickle Cell Disease

  • Sickle cell disease is a serious inherited genetic blood disorder characterized by abnormal hemoglobin that causes red blood cells to become sickle-shaped, leading to chronic hemolytic anemia, painful vaso-occlusive crises, and progressive multi-organ damage 1, 2

Pathophysiology

  • Sickle cell disease results from a genetic mutation - a C to A substitution at codon 6 of the beta globin gene, replacing glutamic acid with valine, creating abnormal hemoglobin S (HbS) 3
  • When deoxygenated, HbS molecules form polymers causing red blood cells to deform into the characteristic sickle shape 4
  • This sickling process leads to damaged red cell membranes and cytoskeleton, irreversibly sickled cells and hemolysis, and vaso-occlusion, ischemia-reperfusion injury, and end-organ damage 4, 5
  • Intravascular hemolysis causes nitric oxide depletion and free heme release, worsening vascular endothelial damage 5

Genetic Patterns and Prevalence

  • SCD is one of the most common serious inherited conditions globally, diagnosed in more than 1:2000 live births in England annually 6
  • Patients may have homozygous sickle gene (HbSS - sickle cell anemia) or compound heterozygous state with another abnormal hemoglobin (e.g., HbSC, HbS-β-thalassemia) 1, 6
  • The heterozygous carrier state (HbAS or sickle cell trait) is generally benign 2
  • SCD predominantly affects people of African or Caribbean background (98% in UK registry), but also occurs in families from the Middle East, India, and Mediterranean regions 6

Clinical Manifestations

  • Painful vaso-occlusive crises are severe acute pain episodes 3
  • Stroke is a potentially life-threatening complication presenting with hemiparesis, aphasia, seizures, severe headache, or altered consciousness 7
  • Splenic sequestration is a rapid enlargement of the spleen with trapped blood 7
  • Transient aplastic crisis is an exacerbation of anemia with decreased reticulocyte count, often triggered by parvovirus B19 7
  • Priapism is a prolonged painful erection, occurring in two forms: stuttering episodes lasting <4 hours and severe acute ischemic episodes lasting ≥4 hours 7

Chronic Complications

  • Chronic hemolytic anemia is a common complication 2
  • Progressive multi-organ damage affects the eyes (retinopathy) and lungs (pulmonary hypertension) 6
  • Increased susceptibility to infections, particularly pneumococcal, is a significant concern 7
  • Neuropsychological impairment affects school and job performance 7

Disease Severity and Variants

  • Severity varies by genotype and within genotypes 3
  • Severe forms include HbSS (sickle cell anemia) and HbSβ0-thalassemia, typically presenting with early onset of painful crises, severe anemia, and more frequent complications 3
  • Higher fetal hemoglobin (HbF) levels (>8%) are associated with milder disease phenotype 3

Management Approaches

  • Regular blood transfusions may be needed for certain complications, particularly stroke prevention 8

Prognosis

  • With optimal multidisciplinary care, survival into the 7th decade can be expected 6
  • Death in childhood is now uncommon in the UK (1-2%) 6

Important Considerations

  • Patients with SCD are at increased risk of complications during surgery and anesthesia 9
  • Iron supplementation should not be given unless iron deficiency is biochemically proven, due to risk of iron overload from repeated transfusions 7
  • Regular screening and preventive care are essential to reduce complications and improve quality of life 7